Quetiapine Fumarate Patent Expiration

Quetiapine Fumarate is Used for treating major depressive disorder (MDD) and schizophrenia. It was first introduced by Cheplapharm Arzneimittel Gmbh in its drug Seroquel on Sep 26, 1997. Another drug containing Quetiapine Fumarate is Seroquel Xr. 29 different companies have introduced drugs containing Quetiapine Fumarate.


Quetiapine Fumarate Patents

Given below is the list of patents protecting Quetiapine Fumarate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Seroquel Xr US5948437

(Pediatric)

Pharmaceutical compositions using thiazepine Nov 28, 2017

(Expired)

Cheplapharm
Seroquel Xr US5948437 Pharmaceutical compositions using thiazepine May 28, 2017

(Expired)

Cheplapharm



Quetiapine Fumarate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Quetiapine Fumarate Generic API Manufacturers

Several generic applications have been filed for Quetiapine Fumarate. The first generic version for Quetiapine Fumarate was by Teva Pharmaceuticals Usa and was approved on Mar 27, 2012. And the latest generic version is by Graviti Pharmaceuticals Private Ltd and was approved on Nov 26, 2024.

Given below is the list of companies who have filed for Quetiapine Fumarate generic, along with the locations of their manufacturing plants worldwide.